Esteatosis hepática y resistencia a la insulina: ¿qué ocurre primero?

From the therapeutic point of view, several treatments based on reduction of insulin resistance are being evaluated. In controlled studies these treatments have reduced the degree of fatty infiltration in the liver and in some patients have reversed histological damage.